Signal active
Investment Firm
Overview
Fresenius Medical Care North America is a hospital and health care company that focuses on providing healthcare services to people with renal and other chronic conditions. It offers dialysis facilities, outpatient cardiac and vascular labs, and urgent care centers.
Fresenius Medical Care North America (FMCNA) is one of the largest providers of dialysis products and services. It has raised a record amount of money to support the goals and initiatives of the National Kidney Foundation (NKF) over the course of a two-year partnership.
Fresenius Medical Care North America was founded in 1996 by Bill Valle and it is headquartered in Waltham, Massachusetts.
Highlights
1996
Biotechnology
10001+
4
3
undefined
Early Stage Venture
N/A
Location
Waltham, Massachusetts, United States, North America
Contact Information
Social
Profile Resume
Fresenius Medical Care North America, established in 1996 and headquartered in United States, North America., specializes in Early Stage Venture investments across Software, Biotechnology, Hardware, Financial Services, Health Care, Medical Device, Education, mHealth, Enterprise Software, Venture Capital. Their recent investments include Retia Medical, Red Cedar Ventures, BioIntelliSense, 7wire Ventures, iD Ventures America. The highest investment round they participated in was $4.7B. Among their most notable exits are Retia Medical and Red Cedar Ventures. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
4
0
3
undefined
Investments
4
Annouced Date | Organization Name | Industry | Money Raised |
---|---|---|---|
Jul 09, 2019 | BioIntelliSense | Biotechnology | 25.0M |
Dec 18, 2019 | InterWell Health | Health Care | 20.0M |
Jul 28, 2021 | BioIntelliSense | Biotechnology | 45.0M |
Jul 18, 2022 | Retia Medical | Software | 15.0M |
Exits
0
Funding Timeline
4
1
0
Funding Rounds
4
Fresenius Medical Care North America has raised 4 rounds. Their latest funding was raised on Jul 18, 2022 from a Series B - Retia Medical round.
Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
---|---|---|---|---|
Jul 09, 2019 | Series A - BioIntelliSense | - | 25.0M | - |
Dec 18, 2019 | Series A - InterWell Health | - | 20.0M | - |
Jul 28, 2021 | Series B - BioIntelliSense | - | 45.0M | - |
Jul 18, 2022 | Series B - Retia Medical | - | 15.0M | - |
Investors
26
Fresenius Medical Care North America is funded by 26 investor(s). U.S. Department of Veteran Affairs Kantor is the most recent investors.
Investor Name | Lead Investor | Funding Round | Money Raised |
---|---|---|---|
- | No | Post-IPO Equity - Fresenius Medical Care North America | 2.9M |
- | No | Post-IPO Equity - Fresenius Medical Care North America | 3.4M |
- | No | Post-IPO Equity - Fresenius Medical Care North America | 16.4M |
- | No | Post-IPO Equity - Fresenius Medical Care North America | 5.5M |
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
Annouced Date | Fund Name | Money Raised |
---|---|---|
May 10, 2013 | OTPPLESS | 1.0M |
May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
News
Mar 25, 2024
Fresenius Medical Care - Health Equity in Kidney Care: Interview with Lorien Dalrymple, MD, MPH
News
Nov 06, 2023
Fresenius Medical Care - Positive Purchasing Power
News
Oct 31, 2023
PR Newswire - Fresenius Medical Care appoints Craig Cordola as new Management Board member for Care Delivery
Funding Round
Jul 18, 2022
Retia Medical raised $15000000 on 2022-07-18 in Series B
Funding Round
Jul 28, 2021
BioIntelliSense raised $45000000 on 2021-07-28 in Series B
Funding Round
Dec 18, 2019
InterWell Health raised $20000000 on 2019-12-18 in Series A